Abstract |
In the Netherlands, medical treatment to women with a non-vital pregnancy is provided in secondary care. In a Dutch pilot study, it has been shown that treatment of a missed miscarriage with misoprostol in primary care is an acceptable alternative. However, there are clear indications that medical treatment in women with a non-vital pregnancy is greatly improved when mifepristone is prescribed in addition to misoprostol. The authors state that this treatment is also justified in primary care.
|
Authors | Peter Leusink, Gunilla Kleiverda |
Journal | Nederlands tijdschrift voor geneeskunde
(Ned Tijdschr Geneeskd)
Vol. 165
(02 18 2021)
ISSN: 1876-8784 [Electronic] Netherlands |
Vernacular Title | Prescriptie van mifepriston in de eerste lijn? |
PMID | 33651509
(Publication Type: Journal Article)
|
Chemical References |
- Abortifacient Agents, Nonsteroidal
- Misoprostol
- Mifepristone
|
Topics |
- Abortifacient Agents, Nonsteroidal
(therapeutic use)
- Abortion, Legal
- Abortion, Missed
(drug therapy)
- Adult
- Drug Therapy, Combination
- Female
- Humans
- Mifepristone
(therapeutic use)
- Misoprostol
(therapeutic use)
- Netherlands
- Pilot Projects
- Pregnancy
- Primary Health Care
|